Therefore, we collected and compared the plasma exosomes of patients with and without trastuzumab resistance and identified the lncRNA Linc00969, which was overexpressed in HER-2+ BC patients with trastuzumab resistance. This evidence concerns the gene ERBB2 and breast cancer.